Clinical Education and Strategies for Trauma-Informed Approaches to Pharmacy-Led HIV Prevention Efforts

Pharmacists are positioned to play a critical role in shifting who has access to tools for HIV prevention by making HIV Pre-Exposure Prophylaxis (PrEP) and HIV Post-Exposure Prophylaxis (PEP) more visible and accessible to those who stand to benefit most.

The individuals most at risk of acquiring HIV in their lifetime are also more likely to experience stigma from providers and encounter significant barriers to care. Those same individuals are also more likely to engage with their community pharmacy than with other healthcare providers.

Pharmacists play a vital role in reducing the number of new HIV diagnoses by making PrEP and PEP more visible and equitably accessible at pharmacies, and by providing care that is trauma-informed and culturally aware.

End HIV/STI Oregon is a statewide initiative to end new HIV transmissions in Oregon. Since its launch in December 2016, public and private partners from communities across Oregon have been working to raise awareness, increase testing, prevent new infections, provide treatment, and end the inequities that fuel the transmission of HIV and other sexually transmitted infections (STIs). Oregon pharmacists are key partners in these efforts! Specifically, pharmacists and technicians play an important role in helping more people access PrEP and PEP, especially in rural areas. Thank you for your efforts to end new HIV and STI transmissions in Oregon! - Oregon Health Authority, Public Health Division

This training was made possible in consideration of and recognizes the work of the CDC Division of HIV Prevention (DHP). For more information, please visit https://www.cdc.gov/hiv/default.html

Accreditation Council for Pharmacy Education Information:

This program has been planned and implemented in accordance with the policies of the Accreditation Council for Pharmacy Education through the sponsorship of OSU College of Pharmacy. The OSU College of Pharmacy is approved by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Upon completion of this activity, participants will receive a Statement of Completion, and a Statement of Credit shall be uploaded to CPE Monitor. Completion requires 1) Registration for the course 2) Completion of all modules 3) Passing a final exam with 80% or higher and 4) Completion of the program evaluation.

At the completion of this activity, the participant will be able to:

1. Describe HIV epidemiology in Oregon and the United States
2. Identify the pharmacist's role in ending new HIV infections
3. Review the HIV life cycle, disease progression, transmission, and risk
4. Distinguish methods of HIV prevention, focusing on PrEP and PEP
5. Utilize affirming language to recognize the diversity of lived experience as it relates to PrEP and PEP
6. Examine assessing for possible acute HIV infection based on the timeline of exposure
7. Describe HIV PrEP and HIV PEP medications regimens, side effects, and drug interactions
8. Apply the process of assessing a patient for HIV PrEP or HIV PEP through case examples
9. Discuss PrEP and PEP medication adherence strategies
10. Differentiate laboratory results needed for PrEP initiation and continuation
11. Recall strategies for delivering reactive test results to individuals
12. Compare HIV acquisition risk factors
13. Describe how trauma impacts health outcomes
14. Recognize how trauma shows up in patients and the healthcare workforce
15. Utilize trauma-informed approaches to engage patients in HIV prevention services in pharmacy settings

UAN: 0036-0000-23-005-H02-P
Target Audience: Pharmacists licensed in the state of Oregon
Activity Type: Application
Activity Release Date: 12/01/2023
Activity Expiration Date: 12/01/2026